These results are consistent with the previous report that inhibition of LSD1 by siRNA inhibited the growth of HepG2 subcutaneous tumor,12 supporting that LSD1 plays an important role in HCC progression and its potential value as a promising target of HCC therapy. This evidence concerns the gene KDM1A and hepatocellular carcinoma.